A phase II basket trial of dual anti–CTLA-4 and anti–PD-1 blockade in rare tumors (DART) SWOG S1609: The desmoid tumors (cohort 27).

Authors

Young Kwang Chae

Young Kwang Chae

Northwestern University, Chicago, IL

Young Kwang Chae , Megan Othus , Sandip Pravin Patel , Benjamin Powers , Chung-Tsen Hsueh , Rangaswamy Govindarajan , Silvana Z. Bucur , Liam Il-Young Chung , Christine McLeod , Helen X. Chen , Elad Sharon , Howard Streicher , Christopher W. Ryan , Charles David Blanke , Razelle Kurzrock

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT02834013

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr 11516)

DOI

10.1200/JCO.2023.41.16_suppl.11516

Abstract #

11516

Poster Bd #

450

Abstract Disclosures

Similar Posters

First Author: Young Kwang Chae

Poster

2019 ASCO Annual Meeting

SWOG 1609 (DART): A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors.

SWOG 1609 (DART): A phase II basket trial of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors.

First Author: Sandip Pravin Patel

First Author: Geoffrey Thomas Gibney

First Author: James Lin Chen